Home » Topics » HIV/AIDS, BioWorld Science

HIV/AIDS, BioWorld Science
RSS

Novel HIV-1-specific bNAb can achieves near pan-neutralization of HIV-1

Dec. 14, 2016

New phase I trial explores use of PGT-121 for HIV prevention and therapy

Dec. 12, 2016

Abivax provides update on clinical development program for ABX-464

Dec. 9, 2016

HVTN initiates phase IIb/III trial of investigational HIV vaccine regimen in South Africa

Nov. 28, 2016

Institute of Human Virology announces grants and new international center to tackle HIV/AIDS

Nov. 24, 2016

Yisheng Biopharma to collaborate with The Scripps Research Institute in developing new AIDS vaccine

Nov. 15, 2016

VRC-01 only slightly delays HIV rebound in clinical studies

Nov. 11, 2016

TaiMed Biologics notifies Theratechnologies of preliminary results for phase III trial of ibalizumab

Nov. 11, 2016

ViiV Healthcare UK discloses antiviral agents

Nov. 10, 2016

Anti-alpha4beta7 MAb regimen leads to SIV suppression long after treatment in monkeys

Nov. 2, 2016

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...